Subscribe to RSS
DOI: 10.1055/a-2028-7784
A Neonate with Mucopolysaccharidosis Type VII with Intractable Ascites
Abstract
We report a case of a patient with severe fetal hydrops and refractory ascites, diagnosed as mucopolysaccharidosis type VII (MPS VII) by whole-exome sequencing, and discharged at 5 months of age after long-term ventilatory management. A male neonate was born by emergency cesarean section due to fetal distress at 301/7 weeks' gestation. Physical examination and X-rays revealed pleural effusion, ascites, and generalized edema, indicating severe fetal hydrops. He underwent tracheal intubation because of respiratory distress that was attributed to massive ascites, pulmonary hypoplasia, and pulmonary hypertension. He received mechanical ventilation and inhaled nitric oxide therapy. Prednisone, octreotide, and a factor XIII preparation were used as the treatment for ascites, and the ascites gradually decreased. He was extubated within 2 months of age. At 4 months of age, the results of whole-exome sequencing of the cord blood showed a compound heterozygous mutation in the GUSB gene, the gene responsible for MPS VII. Enzyme replacement therapy was initiated, and the ascites was resolved. Careful systemic management, including lung-protective respiratory management and the early establishment of nutrition, is important for the long-term survival of infants with fetal hydrops, and early aggressive workup, including whole-genome sequencing for the cause, should be performed in the case of refractory ascites.
Publication History
Received: 23 September 2022
Accepted: 18 January 2023
Accepted Manuscript online:
06 February 2023
Article published online:
16 March 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Sly WS, Quinton BA, McAlister WH, Rimoin DL. Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J Pediatr 1973; 82 (02) 249-257
- 2 Montaño AM, Lock-Hock N, Steiner RD. et al. Clinical course of sly syndrome (mucopolysaccharidosis type VII). J Med Genet 2016; 53 (06) 403-418
- 3 Poorthuis BJ, Wevers RA, Kleijer WJ. et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 1999; 105 (1-2): 151-156
- 4 Van Dorpe J, Moerman P, Pecceu A, Van den Steen P, Fryns JP. Non-immune hydrops fetalis caused by beta-glucuronidase deficiency (mucopolysaccharidosis VII). Study of a family with 3 affected siblings. Genet Couns 1996; 7 (02) 105-112
- 5 Whybra C, Mengel E, Russo A. et al. Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature. Orphanet J Rare Dis 2012; 7: 86
- 6 Saxonhouse MA, Behnke M, Williams JL, Richards D, Weiss MD. Mucopolysaccharidosis Type VII presenting with isolated neonatal ascites. J Perinatol 2003; 23 (01) 73-75
- 7 Walter-Nicolet E, Rakza T, Storme L. et al. A new case of mucopolysaccharidosis VII presenting as non immune hydrops fetalis. Eur J Pediatr 2003; 162 (7-8): 520-521
- 8 Hoyme HE, Jones KL, Higginbottom MC, O'Brien JS. Presentation of mucopolysaccharidosis VII (beta-glucuronidase deficiency) in infancy. J Med Genet 1981; 18 (03) 237-239
- 9 Nelson J. Incidence of the mucopolysaccharidoses in Northern Ireland. Hum Genet 1997; 101 (03) 355-358
- 10 Groener JE, de Graaf FL, Poorthuis BJ, Kanhai HH. Prenatal diagnosis of lysosomal storage diseases using fetal blood. Prenat Diagn 1999; 19 (10) 930-933